Generic drugs don't launch right after patents expire. Legal battles, regulatory delays, and patent thickets can hold them back for years - costing patients billions. Here's how the system really works.
Basal-bolus insulin therapy helps people with diabetes achieve better blood sugar control by combining long-acting and rapid-acting insulin. Learn how to calculate doses, adjust for meals, and avoid common mistakes.
Learn the difference between internal and external hemorrhoids, what causes them, and how to treat them effectively-without unnecessary surgery or unproven remedies. Get practical, science-backed advice for relief and prevention.
Learn how to spot accurate pregnancy medication advice online using trusted sources like MotherToBaby, LactMed, and TIS classifications. Avoid dangerous myths and make informed choices with a simple 3-step verification system.
Digital therapeutics are now FDA-cleared treatments that boost medication adherence-but their interactions with drugs are poorly understood. Learn what you need to know in 2025.
Tirzepatide (Zepbound) is a dual incretin therapy that activates GLP-1 and GIP receptors to promote weight loss. Clinical trials show up to 22.5% body weight reduction, outperforming semaglutide. Learn how it works, what to expect, and how to manage side effects.
Can statins cause insomnia or vivid dreams? Learn which statins are most likely to disrupt sleep, how to tell if it's the medication, and what to do next-backed by clinical studies and patient experiences.
Acetaminophen can ease mild foot pain but won't reduce swelling or fix the cause. Learn when it helps, when it doesn't, and what to do instead for lasting relief.
Combining tricyclic antidepressants like amitriptyline with first-gen antihistamines like Benadryl can cause dangerous anticholinergic overload, leading to confusion, delirium, and increased dementia risk-especially in older adults.
Ezetimibe and bempedoic acid are oral, non-statin medications for lowering LDL cholesterol in people who can't tolerate statins. Both reduce heart risk, with ezetimibe being low-cost and bempedoic acid offering proven cardiovascular benefits.